Luisa María Villar at Universidad de Alcalá - Research Interests, Publications & Academic Profile

Luisa María Villar

Universidad de Alcalá

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Bangladeshi students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

80%

Virology

40%

Multiple Sclerosis

80%

Inflammatory Biology

40%

Neuroinflammation

40%

Immunomodulation

40%

Biomarker Research

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Serum biomarkers at disease onset for personalized therapy in multiple sclerosis

Article Link

Year:

2024

Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults

Article Link

Year:

2024

MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention

Article Link

Year:

2024

Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis

Article Link

Year:

2024

Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis

Article Link

Year:

2024

Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis

Article Link

Year:

2024

Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers

Article Link

Year:

2024

Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine

Article Link

Year:

2023

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure

Article Link

Year:

2023

Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

Article Link

Year:

2023

Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non‐cell‐autonomous neuronal damage

Article Link

Year:

2022

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

Article Link

Year:

2021

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.

Article Link

Year:

2020

Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkers

Article Link

Year:

2020

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process

Article Link

Year:

2020

Collaborators8

Avril Robertson

Affiliate Professor

University of Queensland

AUSTRALIA

Angel Torrado-Carvajal

Assistant Professor

Universidad Rey Juan Carlos

SPAIN

Enric Monreal

Healthcare professional

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

SPAIN

Francisco Pérez-Miralles

Associate Lecturer in Anatomy, Physiology and Neurology of voice, speech and language

University of Valencia

SPAIN

Javier Caballero-Villarraso

SPAIN

Manuel Comabella

SPAIN

Maria Buxó Pujolràs

Institut de Recerca Biomèdica de Lleida

SPAIN

Koen Vandenbroeck

Ikerbasque Research Professor / Dir. Neurogenomiks

Ikerbasque, Basque Foundation for Science

SPAIN

How do Bangladeshi students reach out?

Meet Kite AI